Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Nanomedicine. 2017 Jan 20;13(4):1353–1362. doi: 10.1016/j.nano.2017.01.009

Figure 3.

Figure 3

Daunorubicin-loaded, iron-stabilized micelle formulation (IT-143) demonstrates prolonged circulation compared to unstabilized micelle formulation and free drug in a cannulated rat model. Intravenous administration of IT-143 resulted in exposure to the plasma compartment (AUC0-48h) of 913.7 µg*h/mL compared to 1.5 and 0.96 µg*h/mL for unstabilized micelle formulation and daunorubicin free drug, respectively.